How do I stay healthy? What impact do my environment and lifestyle have on my health? And how can I prevent, treat, or even cure chronic diseases like diabetes, allergies, or lung diseases?
Helmholtz Munich researcher Carsten Marr, Director of the Institute of AI for Health, has acquired a European Research Council (ERC) Proof of Concept Grant for his project on the development of LeukoScreen, an AI-based software to automatically…
The lab of the Institute of Environmental Health at Helmholtz Munich and the Chair of Environmental Medicine at the University of Augsburg has been awarded a certificate of sustainability.
(Long) COVID, vaccination efficacy and immune response: European research project ORCHESTRA finds answers – in broad collaboration
The SARS-CoV-2 pandemic has challenged public health worldwide. The European project ORCHESTRA - Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic - was launched in December 2020 to unite European knowledge…
Four Helmholtz Munich scientists participate in new DFG CRC/TRR
The German Research Foundation funds a new Collaborative Research Centre (CRC)/Transregio (TRR) which aims at employing regulatory T cells to create the basis for tailor-made immunotherapies. This initiative is an alliance of the University Mainz and…
Matthias Tschöp New Vice President of the Helmholtz Association
Prof. Dr. med. Dr. h.c. Matthias H. Tschöp has been the Helmholtz Vice President of Health Research since January 2023. His goal is to accelerate the development of new solutions for the health challenges of our time.
Triple Recognition for Diabetes Research at Helmholtz Munich
Three scientists from Helmholtz Munich and the German Center for Diabetes Research (DZD) were honored with prestigious awards at the annual meeting of the European Association for the Study of Diabetes (EASD) from September 28 to October 2, 2026, in…
Timo Müller Receives 2026 Gill Transformative Investigator Award
Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at Helmholtz Munich and Professor at Ludwig-Maximilians-Universität München (LMU), has received the 2026 Gill Transformative Investigator Award. With this distinction, the Gill…
Funding to Advance Precision Medicine for Inflammatory Bowel Disease in Children
Daniel Kotlarz, group leader at the Institute of Translational Genomics at Helmholtz Munich and Heisenberg Professor of Precision Medicine of Pediatric Inflammatory Bowel Diseases at LMU University Hospital Munich receives around 600,000 Euros…
